Literature DB >> 20226634

Antimicrobial susceptibility of Gram-positive non-urinary isolates to fosfomycin.

Matthew E Falagas1, Sofia Maraki, Drosos E Karageorgopoulos, Antonia C Kastoris, Anastasios Kapaskelis, George Samonis.   

Abstract

We aimed to evaluate the antimicrobial activity of fosfomycin against Gram-positive non-urinary isolates collected at the microbiological laboratory of the University Hospital of Heraklion, Crete, Greece, in 2008. Susceptibility testing was performed by the disk diffusion method for a total of 1846 isolates; 1275 isolates (69.1%) were susceptible to fosfomycin. Specifically, 416/419 Staphylococcus aureus (99.3%) [including 129/130 meticillin-resistant S. aureus (MRSA) isolates] and 745/961 coagulase-negative staphylococci (77.5%) were susceptible to fosfomycin. Among 42 Streptococcus pneumoniae, 64 Streptococcus pyogenes and 93 other streptococcal isolates, 61.9%, 40.6% and 48.4%, respectively, were susceptible to fosfomycin. Fosfomycin was inactive against the 166 enterococcal isolates tested. This old antibiotic may deserve consideration for further studies and use in clinical practice, especially for S. aureus (including MRSA) infections. Copyright 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20226634     DOI: 10.1016/j.ijantimicag.2010.01.010

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  11 in total

Review 1.  Fosfomycin: Resurgence of an old companion.

Authors:  Sangeeta Sastry; Yohei Doi
Journal:  J Infect Chemother       Date:  2016-02-28       Impact factor: 2.211

2.  Analysis of urine-specific antibiograms from veterans to guide empiric therapy for suspected urinary tract infection.

Authors:  Ketzela J Marsh; Lesley Mundy; John J Holter; James R Johnson
Journal:  Diagn Microbiol Infect Dis       Date:  2019-07-30       Impact factor: 2.803

Review 3.  A reappraisal of current dosing strategies for intravenous fosfomycin in children and neonates.

Authors:  Friederike Traunmüller; Martin Popovic; Karl-Heinz Konz; Patrick Vavken; Andreas Leithner; Christian Joukhadar
Journal:  Clin Pharmacokinet       Date:  2011-08       Impact factor: 6.447

Review 4.  Coagulase-negative staphylococci.

Authors:  Karsten Becker; Christine Heilmann; Georg Peters
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  Serratia infections in a general hospital: characteristics and outcomes.

Authors:  G Samonis; E K Vouloumanou; M Christofaki; D Dimopoulou; S Maraki; E Triantafyllou; D P Kofteridis; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-10       Impact factor: 3.267

Review 6.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

Review 7.  The Potential Role of Fosfomycin in Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.

Authors:  Grace Li; Joseph F Standing; Julia Bielicki; William Hope; John van den Anker; Paul T Heath; Mike Sharland
Journal:  Drugs       Date:  2017-06       Impact factor: 9.546

8.  The potential of fosfomycin for multi-drug resistant sepsis: an analysis of in vitro activity against invasive paediatric Gram-negative bacteria.

Authors:  Phoebe C M Williams; Joseph Waichungo; N Claire Gordon; Mike Sharland; Sheila Murunga; Alice Kamau; James A Berkley
Journal:  J Med Microbiol       Date:  2019-04-17       Impact factor: 2.472

9.  Mutations of the Transporter Proteins GlpT and UhpT Confer Fosfomycin Resistance in Staphylococcus aureus.

Authors:  Su Xu; Zhuyingjie Fu; Ying Zhou; Yang Liu; Xiaogang Xu; Minggui Wang
Journal:  Front Microbiol       Date:  2017-05-19       Impact factor: 5.640

10.  Prevalence of Fosfomycin Resistance and Mutations in murA, glpT, and uhpT in Methicillin-Resistant Staphylococcus aureus Strains Isolated from Blood and Cerebrospinal Fluid Samples.

Authors:  Zhuyingjie Fu; Ying Ma; Chunhui Chen; Yan Guo; Fupin Hu; Yang Liu; Xiaogang Xu; Minggui Wang
Journal:  Front Microbiol       Date:  2016-01-11       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.